{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:33:48Z","timestamp":1779348828504,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.clim.2014.05.006","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T07:45:59Z","timestamp":1400744759000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Regulatory T cells control diabetes without compromising acute anti-viral defense"],"prefix":"10.1016","volume":"153","author":[{"given":"Carmen","family":"Baca Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe P.","family":"Pagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Fousteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sowbarnika","family":"Sachithanantham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Rodriguez-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7900-8475","authenticated-orcid":false,"given":"Jacqueline","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"von Herrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2014.05.006_bb0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2006.08.003","article-title":"From vanilla to 28 flavors: multiple varieties of T regulatory cells","volume":"25","author":"Shevach","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0015","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.172.6.1701","article-title":"OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset","volume":"172","author":"Powrie","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0030","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0035","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus. A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0040","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-1023","article-title":"Viral trigger for type 1 diabetes: pros and cons","volume":"57","author":"Filippi","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2014.05.006_bb0045","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.clim.2014.05.006_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2014.05.006_bb0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.coi.2005.09.013","article-title":"Genetic susceptibility to type 1 diabetes","volume":"17","author":"Maier","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1101\/gr.214102. Article published online before print in January 2002","article-title":"Combining mouse congenic strains and microarray gene expression analyses to study a complex trait: the NOD model of type 1 diabetes","volume":"12","author":"Eaves","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.clim.2014.05.006_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0075","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nm924","article-title":"TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes","volume":"9","author":"Belghith","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0080","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.171.8.4040","article-title":"Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development","volume":"171","author":"Gregori","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0085","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1073\/pnas.172382999","article-title":"Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice","volume":"99","author":"Wu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2014.05.006_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2014.05.006_bb0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/diabetes.54.2.306","article-title":"Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes","volume":"54","author":"Jaeckel","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2014.05.006_bb0100","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2337\/diabetes.54.4.1040","article-title":"In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3","volume":"54","author":"Lundsgaard","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2014.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0110","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.4049\/jimmunol.161.5.2620","article-title":"Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate \u201cactive tolerance\u201d in the nonobese diabetic mouse","volume":"161","author":"Herbelin","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.164.1.240","article-title":"Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice","volume":"164","author":"Lepault","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0120","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127\u2212 regulatory T cells preserves beta-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clim.2014.05.006_bb0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2013.05.001","article-title":"Anti-CD3 clinical trials in type 1 diabetes mellitus","volume":"149","author":"Daifotis","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0130","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.2337\/db13-0345","article-title":"Teplizumab (anti-CD3 mAb) treatment preserves c-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders","volume":"62","author":"Herold","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2014.05.006_bb0135","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/blood-2009-02-204875","article-title":"Transient Epstein\u2013Barr virus reactivation in CD3 monoclonal antibody-treated patients","volume":"115","author":"Keymeulen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2014.05.006_bb0140","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2010.04.002","article-title":"Immunotherapy of type 1 diabetes: where are we and where should we be going?","volume":"32","author":"Luo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(91)90164-T","article-title":"Ablation of \u201ctolerance\u201d and induction of diabetes by virus infection in viral antigen transgenic mice","volume":"65","author":"Ohashi","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.clim.2014.05.006_bb0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.clim.2014.05.006_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ddmod.2009.03.008","article-title":"Mouse models for type 1 diabetes","volume":"6","author":"Van Belle","year":"2009","journal-title":"Drug Discov. Today Dis. Model."},{"key":"10.1016\/j.clim.2014.05.006_bb0160","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.4049\/jimmunol.165.10.5945","article-title":"Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes","volume":"165","author":"Holz","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0165","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O","article-title":"Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection","volume":"28","author":"Oxenius","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0175","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0180","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/nprot.2007.258","article-title":"In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells","volume":"2","author":"Fantini","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.clim.2014.05.006_bb0185","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2004-03-1211","article-title":"Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells","volume":"105","author":"Levings","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2014.05.006_bb0190","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0195","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.4049\/jimmunol.166.12.7282","article-title":"A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood","volume":"166","author":"Yamagiwa","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0200","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2014.05.006_bb0205","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jir.2006.0144","article-title":"IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets","volume":"27","author":"Ye","year":"2007","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.clim.2014.05.006_bb0210","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0215","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/eji.200839196","article-title":"Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions","volume":"39","author":"Duarte","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2013.10.016","article-title":"Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response","volume":"39","author":"Bailey-Bucktrout","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","article-title":"Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells","volume":"36","author":"Miyao","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0240","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.immuni.2009.09.023","article-title":"T cell receptor CDR3 sequence but not recognition characteristics distinguish autoreactive effector and Foxp3(+) regulatory T cells","volume":"31","author":"Liu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2014.05.006_bb0245","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.1191996","article-title":"Stability of the regulatory T cell lineage in vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.clim.2014.05.006_bb0250","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.immunol.021908.132723","article-title":"Regulatory T cells in the control of host\u2013microorganism interactions (*)","volume":"27","author":"Belkaid","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2014.05.006_bb0255","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.0707453104","article-title":"Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host","volume":"104","author":"Easterbrook","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2014.05.006_bb0260","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","article-title":"Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection","volume":"31","author":"Oldenhove","year":"2009","journal-title":"Immunity"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614001338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614001338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T09:50:42Z","timestamp":1689241842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661614001338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1521661614001338"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2014.05.006","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T cells control diabetes without compromising acute anti-viral defense","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2014.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}